摘要 |
The invention is directed to methods of treating, preventing, or inhibiting a Hepatitis C viral infection in a mammal comprising contacting the mammal with an effective amount of a compound of the formula: Wherein substitutions at R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>-R<SUB>12</SUB>, and Y are set forth in the specification.
|